4//SEC Filing
Kaldor Stephen W 4
Accession 0001181431-13-016742
CIK 0001484478other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:11 PM ET
Size
12.6 KB
Accession
0001181431-13-016742
Insider Transaction Report
Form 4
Kaldor Stephen W
Director
Transactions
- Exercise/Conversion
Common Stock
2013-03-11$13.94/sh+8,000$111,520→ 8,000 total - Exercise/Conversion
Stock Options (to buy)
2013-03-11−8,000→ 5,012 totalExercise: $13.94Exp: 2021-05-19→ Common Stock (8,000 underlying) - Sale
Common Stock
2013-03-11$41.74/sh−5,379$224,519→ 2,621 total - Sale
Common Stock
2013-03-12$40.71/sh−973$39,611→ 1,648 total
Holdings
- 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying) - 17,500
Stock Options (to buy)
Exercise: $18.22Exp: 2022-05-24→ Common Stock (17,500 underlying)
Footnotes (3)
- [F1]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F2]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F3]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeother
Related Parties
1- filerCIK 0001507502
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 6:11 PM ET
- Size
- 12.6 KB